Pretreatment with EPO reduces the injury and dysfunction caused by ischemia/reperfusion in the mouse kidney in vivo
- 1 September 2004
- journal article
- Published by Elsevier in Kidney International
- Vol. 66 (3) , 983-989
- https://doi.org/10.1111/j.1523-1755.2004.00847.x
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Endothelial progenitor cell proliferation and differentiation is regulated by erythropoietin Rapid CommunicationKidney International, 2003
- Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilizationBlood, 2003
- Hypoxia-Induced Stroke Tolerance in the Mouse Is Mediated by ErythropoietinStroke, 2003
- Preconditioning with erythropoietin protects against subsequent ischemia‐reperfusion injury in rat kidneyThe FASEB Journal, 2003
- Hearts From Rodents Exposed to Intermittent Hypoxia or Erythropoietin Are Protected Against Ischemia-Reperfusion InjuryCirculation, 2003
- Hematopoietic Stem Cells Contribute to the Regeneration of Renal Tubules after Renal Ischemia-Reperfusion Injury in MiceJournal of the American Society of Nephrology, 2003
- GW274150, a potent and highly selective inhibitor of iNOS, reduces experimental renal ischemia/reperfusion injuryKidney International, 2003
- Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI)Circulation, 2002
- Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stressProceedings of the National Academy of Sciences, 2001
- Recombinant human erythropoietin inhibits iNOS activity and reverts vascular dysfunction in splanchnic artery occlusion shockBritish Journal of Pharmacology, 1999